Nintedanib brought modest benefit to IPF & SSc-ILD, but now ILD in other autoimmune dx as well? Small but real diff in lung volumes, no diff in QOL or acute exac/deaths, diarrhea but largely not limiting in study. Works in absence of alt, but worth it? #ACR19 ABST0374 @RheumNow https://t.co/1CDTgiQkMd